Lataa...
Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
BACKGROUND: Droxidopa is an orally active prodrug that significantly improved dizziness/lightheadedness measured using the Orthostatic Hypotension Symptom Assessment (OHSA) Item 1 in patients with neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson disease, multip...
Tallennettuna:
| Julkaisussa: | BMC Neurol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4990877/ https://ncbi.nlm.nih.gov/pubmed/27538531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-016-0665-5 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|